IL22 and psoriasis: To validate the data obtained by microarray, we performed qRT-PCR and included AD like conditions (IL-4 and IL-13 treatment) as well as psoriasis like conditions (IL-22, OSM, IL-17, and TNFα treatment) in our experimental setup.